Reversible effects on female rat fertility with abrocitinib, a Janus kinase 1 inhibitor
Sign Up to like & getrecommendations! Published in 2024 at "Birth Defects Research"
DOI: 10.1002/bdr2.2345
Abstract: Abrocitinib is a Janus kinase (JAK) 1 selective inhibitor approved for the treatment of atopic dermatitis. Female reproductive tissues were unaffected in general toxicity studies, but an initial female rat fertility study resulted in adverse… read more here.
Keywords: fertility; rat fertility; janus kinase; abrocitinib janus ... See more keywords